3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Medicine Man Technologies's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 13.91%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Medicine Man Technologies's 3-Year ROIIC % or its related term are showing as below:
SHWZ's 3-Year ROIIC % is ranked better than 68.81% of 622
companies
in the Healthcare Providers & Services industry
Industry Median: 1.16
vs SHWZ: 13.91
Medicine Man Technologies 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medicine Man Technologies's 3-Year ROIIC %
For the Pharmaceutical Retailers subindustry, Medicine Man Technologies's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicine Man Technologies's 3-Year ROIIC % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicine Man Technologies's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Medicine Man Technologies's 3-Year ROIIC % falls into.
Medicine Man Technologies 3-Year ROIIC % Calculation
Medicine Man Technologies's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Medicine Man Technologies (OTCPK:SHWZ) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Medicine Man Technologies 3-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Medicine Man Technologies's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company's business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHWZ has been successfully added to your 